CN101322811B - Chinese medicine for treating epistaxis - Google Patents

Chinese medicine for treating epistaxis Download PDF

Info

Publication number
CN101322811B
CN101322811B CN2008101385203A CN200810138520A CN101322811B CN 101322811 B CN101322811 B CN 101322811B CN 2008101385203 A CN2008101385203 A CN 2008101385203A CN 200810138520 A CN200810138520 A CN 200810138520A CN 101322811 B CN101322811 B CN 101322811B
Authority
CN
China
Prior art keywords
chinese medicine
radix
epistaxis
treatment
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101385203A
Other languages
Chinese (zh)
Other versions
CN101322811A (en
Inventor
时新杰
房莉敏
于冬春
刘运波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101385203A priority Critical patent/CN101322811B/en
Publication of CN101322811A publication Critical patent/CN101322811A/en
Application granted granted Critical
Publication of CN101322811B publication Critical patent/CN101322811B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a traditional Chinese medicine for treating epistaxis, which consists of the following materials in components by weight: 30g to 40g of pasqueflower, 20g to 30g of liriopespicta, 15g to 20g of achyranthes, bidentatae, 25g to 30g of ruddle, 25g to 30g of agrimony, 30 to 40g of rhizoma imperatae, 10g to 15g of yam, 15g to 20g of white peony root, 10g to 15g of chinese data, and 6g to 10g of liquorice. The traditional Chinese medicine of the invention has the advantages of simple preparation method, low cost, wide material sources, convenient use, good curative effect, high recovery rate and no toxic or side effect with the effective rate of 100 percent and the recovery rate of over 85 percent.

Description

A kind of Chinese medicine for the treatment of epistaxis
Technical field
The present invention relates to field of Chinese herbal, specifically a kind of Chinese medicine for the treatment of epistaxis.
Background technology
Epistaxis is nasal bleeding, is a clinical common symptom.How because of lack of lung-YIN, due to asthenic fire superinverse or depression of liver-QI, strongly fragrant fire-transformation of a specified duration, the absurd row of forcing blood.Medical Treasures of the Golden Chamber cloud: " inspiratory dyspnea due to ascending pathogenic fire, discomfort in the throat." ancients' cloud: " excessive QI becoming fire ".Die Chinese traditional treatment epistaxis with nourishing YIN and moistening the lung, heat-clearing and toxic substances removing, suppressing hyperactive liver for descending adverse qi, astringing to arrest bleeding are the rule of treatment.
Summary of the invention
Purpose of the present invention just provides a kind of Chinese medicine for the treatment of epistaxis, and it follows the prescription principle of medication of the traditional Chinese medical science, can treat epistaxis effectively, and have no side effect.
For achieving the above object, a kind of Chinese medicine for the treatment of epistaxis, it is characterized in that it is made up of the component of following raw materials in weight drug ratio, Radix Pulsatillae 30-40g, Radix Ophiopogonis 20-30g, Radix Achyranthis Bidentatae 15-20g, Haematitum 25-30g, Herba Agrimoniae 25-30g, Rhizoma Imperatae 30-40g, Rhizoma Dioscoreae 10-15g, Radix Paeoniae Alba 15-20g, Fructus Jujubae 10-15g, Radix Glycyrrhizae 6-10g.
Chinese medicine preparation of the present invention is simple, reasonable, good effect, and the medicine source is wide, and is easy to use, without any side effects, the cure rate height.
The Radix Pulsatillae of Chinese medicine of the present invention bitter in the mouth cold in nature is returned large intestine channel, energy heat-clearing and toxic substances removing, removing heat from blood." not Lu ": " poisonous, cure mainly epistaxis." " book on Chinese herbal medicine converges and says ": " removing heat from blood, repercussive are separated noxious dampness." it can also removing heat from the liver in addition, suppressing liver-wind is principal agent.Radix Ophiopogonis is cold in nature, and sweet in the mouth, hardship are returned lung, the heart, stomach warp, the effect nourishing lung-YIN, and reinforcing stomach reg fluid, relieving restlessness clears away heart-fire; Radix Achyranthis Bidentatae: property is flat, and sour in the mouth, hardship are returned liver, kidney channel, energy blood circulation promoting and blood stasis dispelling, the sharp joint of invigorating the liver and kidney, conducting blood to flow downwards; Haematitum, bitter cold is returned liver, heart channel, suppressing the hyperactive liver and subsiding YANG, sending down the abnormal ascending QI, hemostasis; Rhizoma Imperatae is sweet cold, returns lung, stomach, urinary bladder channel, energy cooling blood for hemostasis, clearing away heat and promoting diuresis; Herba Agrimoniae is flat, and bitter in the mouth, puckery is returned lung, liver, spleen channel, the energy astringing to arrest bleeding; Liver, spleen channel are returned in Radix Paeoniae Alba hardship, acid, cold, energy preserving YIN with astringents and nourishing blood, easing the affected liver to relieve pain, suppressing liver-YANG.Above medicine is assisted the Radix Pulsatillae, replenishing YIN and removing heat, suppressing hyperactive liver for descending adverse qi, astringing to arrest bleeding.Rhizoma Dioscoreae, Fructus Jujubae, Radix Glycyrrhizae, the spleen reinforcing stomach reinforcing, the strong fortune of gas is then failed in lung on the body fluid self energy in making.Cloudy liquid abundance, asthenic fire must be fallen, and liver-fire gets clearly, and epistaxis is from ending.
Chinese medicine of the present invention is decocted in water for oral dose, 1 day 1 dose, decoct twice altogether, fried about 200ml, sooner or later sub-service.Period in a medicine diet suffering, peppery food are not taken by pregnant women.
The present invention verifies that through clinical practice taking medicine 3-6 days is a course of treatment, and general the lighter is promptly healed a course of treatment, and heavy person is promptly healed 3 courses of treatment.Effective percentage 100%, cure rate is more than 85%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1: a kind of Chinese medicine for the treatment of epistaxis, it is characterized in that it is made up of the component of following raw materials in weight drug ratio, Radix Pulsatillae 30-40g, Radix Ophiopogonis 20-30g, Radix Achyranthis Bidentatae 15-20g, Haematitum 25-30g, Herba Agrimoniae 25-30g, Rhizoma Imperatae 30-40g, Rhizoma Dioscoreae 10-15g, Radix Paeoniae Alba 15-20g, Fructus Jujubae 10-15g, Radix Glycyrrhizae 6-10g.Chinese medicine of the present invention is decocted in water for oral dose, 1 day 1 dose, decoct twice altogether, fried about 200ml, sooner or later sub-service.Period in a medicine diet suffering, peppery food are not taken by pregnant women.Effective percentage 100%, cure rate is more than 85%.
Embodiment 2: a kind of Chinese medicine for the treatment of epistaxis, its preferably Radix Pulsatillae 30g, Radix Ophiopogonis 30g, Radix Achyranthis Bidentatae 20g, Haematitum 25g, Herba Agrimoniae 30g, Rhizoma Imperatae 30g, Rhizoma Dioscoreae 15g, Radix Paeoniae Alba 20g, Fructus Jujubae 10g, Radix Glycyrrhizae 10g.
A kind of Chinese medicine clinical efficacy for the treatment of epistaxis is summed up:
One, physical data: this prescription is sutable for men, women, and children.Every because of lack of lung-YIN, the epistaxis due to asthenic fire superinverse or pathogenic fire derived from stagnation of liver-QI, the absurd row of forcing blood all available it.
Two, diagnostic criteria: the one or both sides nasal bleeding, the diseases such as epistaxis due to leukemia and the liver cirrhosis are got rid of in outbreak repeatedly.
Three, instructions of taking: be decocted in water for oral dose, 1 day 1 dose, decoct twice altogether, fried about 200ml, sooner or later sub-service.Period in a medicine diet suffering, peppery food are not taken by pregnant women.
Four, therapeutic effect: taking medicine 3-6 days is a course of treatment, and general the lighter is promptly healed a course of treatment, and heavy person is promptly healed 3 courses of treatment.Effective percentage 100%, cure rate is more than 85%.
Five, model case:
1, opens XX, woman, 18 years old.Go to a doctor in May, 2003, and nasal bleeding is more than 1 year repeatedly, shows effect in the back of getting up the early morning of being everlasting, and multi-treatment is not imitated, and takes 3 courses of treatment, and all diseases disappear, and follows up a case by regular visits to so far recurrence again.
2, old XX, man, 40 years old.In JIUYUE, 2004 is gone to a doctor, epistaxis companion dry nasal cavity repeatedly, the time have dizzy 2 years.Take 2 courses of treatment of our medicine, symptom subtracts greatly, course of treatment of after treatment and fully recovering.
3, in XX, woman, 30 years old.Go to a doctor in May, 2008, repeatedly epistaxis half a year, clothes carbazochrome salicylate, vitamin C etc. are all invalid, examine to give we and take 2 courses of treatment and fully recover, and follow up a case by regular visits to so far, more recurrence.

Claims (1)

1. Chinese medicine for the treatment of epistaxis, it is characterized in that it is made up of the component of following materials of weight proportions medicine, Radix Pulsatillae 30-40g, Radix Ophiopogonis 20-30g, Radix Achyranthis Bidentatae 15-20g, Haematitum 25-30g, Herba Agrimoniae 25-30g, Rhizoma Imperatae 30-40g, Rhizoma Dioscoreae 10-15g, Radix Paeoniae Alba 15-20g, Fructus Jujubae 10-15g, Radix Glycyrrhizae 6-10g.
CN2008101385203A 2008-07-15 2008-07-15 Chinese medicine for treating epistaxis Expired - Fee Related CN101322811B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101385203A CN101322811B (en) 2008-07-15 2008-07-15 Chinese medicine for treating epistaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101385203A CN101322811B (en) 2008-07-15 2008-07-15 Chinese medicine for treating epistaxis

Publications (2)

Publication Number Publication Date
CN101322811A CN101322811A (en) 2008-12-17
CN101322811B true CN101322811B (en) 2011-04-27

Family

ID=40186611

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101385203A Expired - Fee Related CN101322811B (en) 2008-07-15 2008-07-15 Chinese medicine for treating epistaxis

Country Status (1)

Country Link
CN (1) CN101322811B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641532A (en) * 2016-03-16 2016-06-08 曲思廉 Traditional Chinese medicine for treating epistaxis

Also Published As

Publication number Publication date
CN101322811A (en) 2008-12-17

Similar Documents

Publication Publication Date Title
CN103705843B (en) A kind of medicine for the treatment of gastropathy
CN104225441A (en) Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition
CN103520580A (en) Traditional Chinese medicine for treating infantile anorexia
CN102961648A (en) Chinese herbal medicine compound preparation for treating advanced colorectal cancer
CN101745060B (en) Chinese medicament for treating chronic bronchitis
CN103330826B (en) Traditional Chinese medicine composition for treating deficiency of lung yin
CN102526296A (en) Chinese medicinal medicament for treating reflux esophagitis
CN103536881A (en) Drug for treating chronic gastritis
CN101647979B (en) Traditional Chinese medicine for treating bronchial asthma
CN101322811B (en) Chinese medicine for treating epistaxis
CN103263632A (en) Traditional Chinese medicine formula for treating phlegm-accumulating-type globus hystericus
CN105267818B (en) A kind of Chinese medicine composition and preparation method thereof for treating epigastric pain
CN104623148A (en) Medicament for treating cough and asthma and preparation method of oral liquid thereof
CN103110811B (en) Traditional Chinese medicine composition for treating arrhythmia
CN103142965A (en) Traditional Chinese medicine preparation for treating cold drink type children bronchial asthma
CN106075265A (en) The Chinese medicine composition for the treatment of viral influenza
CN104547916A (en) Traditional Chinese medicine decoction for treating coronary heart disease
CN105267791A (en) Distention and fullness treatment traditional Chinese medicine compound and preparation method and application thereof
CN102961476A (en) Chinese patent medicine for treating constipation
CN102284023A (en) Chinese medicinal composition for treating asthma
CN103028088B (en) Traditional Chinese medicine composition for treating coronary heart disease and angina
CN103356841B (en) Traditional Chinese medicine composition for treating abdominal epilepsy
CN103007170B (en) Chinese medicinal composition for treating recurrent oral ulcer
CN102274415B (en) Chinese medicinal composition for treating consumptive disease
CN101596299A (en) A kind of Chinese medicine pill for the treatment of precancerous lesions of chronic atrophic gastritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Shi Xinjie

Inventor after: Fang Limin

Inventor after: Yu Dongchun

Inventor after: Liu Yunbo

Inventor before: Liu Yunbo

Inventor before: Fang Limin

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU YUNBO FANG LIMIN TO: SHI XINJIE FANG LIMIN YU DONGCHUN LIU YUNBO

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110427

Termination date: 20110715